Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site.

作者: R.P. Hertzberg , S.M. Hecht , K.G. Holden , R.K. Johnson , R.W. Busby

DOI: 10.1016/S0021-9258(17)30656-7

关键词:

摘要: Camptothecin (CPT) binds reversibly to, and thereby stabilizes, the cleavable complex formed between DNA topoisomerase I. The nature of interaction CPT with DNA-topoisomerase I binary was studied by use two affinity labeling reagents structurally related to camptothecin: 10-bromoacetamidomethylcamptothecin (BrCPT) 7-methyl-10-bromoacetamidomethylcamptothecin (BrCPTMe). These compounds have been shown trap irreversibly. Although cleavage plasmid mediated camptothecin reduced significantly treatment high salt or excess competitor DNA, enzyme-mediated stabilized BrCTPMe persisted for at least 4 h after similar treatment. production irreversible I-DNA time-dependent, suggesting that BrCPTMe first bound noncovalently enzyme-DNA and, in a second slower step, alkylated enzyme manner prevented ligation. formation covalent linkage supported experiments employed [3H]BrCPT, which label within complex. [3H]BrCPT enhanced greatly presence DNA; very little isolated occurred. Even inhibited camptothecin, both BrCPT same site on studies provide further evidence binding is created as suggest A-ring proximate an residue.

参考文章(41)
Vinayak N. Damle, Margaret McLaughlin, Arthur Karlin, Bromoacetylcholine as an affinity label of the acetylcholine receptor from Torpedo californica Biochemical and Biophysical Research Communications. ,vol. 84, pp. 845- 851 ,(1978) , 10.1016/0006-291X(78)91661-3
B R Samant, F Sweet, 5‘-bromoacetamido-5‘-deoxyadenosine. A novel reagent for labeling adenine nucleotide sites in proteins. Journal of Biological Chemistry. ,vol. 258, pp. 12779- 12782 ,(1983) , 10.1016/S0021-9258(17)44034-8
Grace L Chen, Liu Yang, TC Rowe, Brian D Halligan, Kathleen M Tewey, Leroy F Liu, Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. Journal of Biological Chemistry. ,vol. 259, pp. 13560- 13566 ,(1984) , 10.1016/S0021-9258(17)47282-6
L L Shen, W E Kohlbrenner, D Weigl, J Baranowski, Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. Journal of Biological Chemistry. ,vol. 264, pp. 2973- 2978 ,(1989) , 10.1016/S0021-9258(19)81708-8
Y H Hsiang, R Hertzberg, S Hecht, L F Liu, Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Journal of Biological Chemistry. ,vol. 260, pp. 14873- 14878 ,(1985) , 10.1016/S0021-9258(17)38654-4
J. Mario WOLOSIN, Andrew LYDDIATT, J. Oliver DOLLY, Eric A. BARNARD, Stoichiometry of the Ligand‐Binding Sites in the Acetylcholine‐Receptor Oligomer from Muscle and from Electric Organ FEBS Journal. ,vol. 109, pp. 495- 505 ,(1980) , 10.1111/J.1432-1033.1980.TB04821.X
Michelle G. Lihou, Yaw-Huei Hsiang, Leroy F. Liu, Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin Cancer Research. ,vol. 49, pp. 5077- 5082 ,(1989)
Allan M. Maxam, Walter Gilbert, [57] Sequencing end-labeled DNA with base-specific chemical cleavages Nucleic Acids Part I. ,vol. 65, pp. 499- 560 ,(1980) , 10.1016/S0076-6879(80)65059-9
J J Champoux, R Aronoff, The effects of camptothecin on the reaction and the specificity of the wheat germ type I topoisomerase. Journal of Biological Chemistry. ,vol. 264, pp. 1010- 1015 ,(1989) , 10.1016/S0021-9258(19)85045-7
Robert P. Hertzberg, Mary Jo Caranfa, Radhey S. Gupta, Randall K. Johnson, Warren E. Ross, Richard B. Lock, Barry Eng, Rajni Gupta, Camptothecin-resistant Mutants of Chinese Hamster Ovary Cells Containing a Resistant Form of Topoisomerase I Cancer Research. ,vol. 48, pp. 6404- 6410 ,(1988)